Chk1 has an essential role in the survival of differentiated cortical neurons in the absence of DNA damage

Apoptosis

Volumn 16, Issue 5, 2011, Pages 449-459

  Ye, Weizhen ^a,b,c   Blain, Stacy W ^a,b  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

^c HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Apoptosis; ATR; Chk1; DNA damage response; Neurons; p53

Indexed keywords

7 HYDROXYSTAUROSPORINE; ATM PROTEIN; CAFFEINE; CAMPTOTHECIN; CHECKPOINT KINASE 1; CHECKPOINT KINASE 2; HISTONE H2AX;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN CELL; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DNA DAMAGE; DNA STRAND BREAKAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT;

ANIMALS; APOPTOSIS; CAFFEINE; CAMPTOTHECIN; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; DNA DAMAGE; DNA-BINDING PROTEINS; FEMALE; GENES, P53; GENOMIC INSTABILITY; NEURONS; PHOSPHORYLATION; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, SPRAGUE-DAWLEY; STAUROSPORINE; TUMOR SUPPRESSOR PROTEINS;

EID: 79955799671     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-011-0579-z     Document Type: Article

References (47)

1. RS Cha N Kleckner 2002 ATR homolog Mec1 promotes fork progression, thus averting breaks in replication slow zones Science 297 602 606 12142538 10.1126/science.1071398 1:CAS:528:DC%2BD38XlslWrs7g%3D (Pubitemid 34815344)
2. IM Ward K Minn J Chen 2004 UV-induced ataxia-telangiectasia-mutated and Rad3-related (ATR) activation requires replication stress J Biol Chem 279 9677 9680 14742437 10.1074/jbc.C300554200 1:CAS:528:DC%2BD2cXhvFCht7g%3D (Pubitemid 38372562)
3. LJ Martin Z Liu J Pipino B Chestnut MA Landek 2009 Molecular regulation of DNA damage-induced apoptosis in neurons of cerebral cortex Cereb Cortex 19 1273 1293 18820287 10.1093/cercor/bhn167
4. G Zachos MD Rainey DA Gillespie 2003 Chk1-deficient tumour cells are viable but exhibit multiple checkpoint and survival defects EMBO J 22 713 723 12554671 10.1093/emboj/cdg060 1:CAS:528:DC%2BD3sXitlKksLs%3D (Pubitemid 36193615)
5. RG Syljuasen CS Sorensen LT Hansen, et al. 2005 Inhibition of human Chk1 causes increased initiation of DNA replication, phosphorylation of ATR targets, and DNA breakage Mol Cell Biol 25 3553 3562 15831461 10.1128/MCB.25.9.3553-3562. 2005 1:CAS:528:DC%2BD2MXjvFSmtro%3D (Pubitemid 40559562)
6. EJ Brown D Baltimore 2000 ATR disruption leads to chromosomal fragmentation and early embryonic lethality Genes Dev 14 397 402 10691732 1:CAS:528:DC%2BD3cXhsFCgt70%3D (Pubitemid 30131885)
7. H Takai K Tominaga N Motoyama, et al. 2000 Aberrant cell cycle checkpoint function and early embryonic death in Chk1(-/-) mice Genes Dev 14 1439 1447 10859163 1:CAS:528:DC%2BD3cXksVGnt74%3D (Pubitemid 30421837)
8. AM Casper P Nghiem MF Arlt TW Glover 2002 ATR regulates fragile site stability Cell 111 779 789 12526805 10.1016/S0092-8674(02)01113-3 1:CAS:528:DC%2BD3sXhtVyltg%3D%3D (Pubitemid 36106400)
9. SG Durkin MF Arlt NG Howlett TW Glover 2006 Depletion of CHK1, but not CHK2, induces chromosomal instability and breaks at common fragile sites Oncogene 25 4381 4388 16732333 10.1038/sj.onc.1209466 1:CAS:528: DC%2BD28XnsVaisrg%3D (Pubitemid 44141626)
10. ST Davis BG Benson HN Bramson, et al. 2001 Prevention of chemotherapy-induced alopecia in rats by CDK inhibitors Science 291 134 137 11141566 10.1126/science.291.5501.134 1:CAS:528:DC%2BD3MXisFSisQ%3D%3D (Pubitemid 32056682)
11. A Kubo K Nakagawa RK Varma, et al. 1999 The p16 status of tumor cell lines identifies small molecule inhibitors specific for cyclin-dependent kinase 4 Clin Cancer Res 5 4279 4286 10632371 1:CAS:528:DC%2BD3cXlsV2msw%3D%3D (Pubitemid 30013816)
12. W Ye SW Blain 2010 S phase entry causes homocysteine-induced death while ataxia telangiectasia and Rad3 related protein functions anti-apoptotically to protect neurons Brain 133 2295 2312 20639548
13. SP Crouch R Kozlowski KJ Slater J Fletcher 1993 The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity J Immunol Methods 160 81 88 7680699 10.1016/0022-1759(93)90011-U 1:CAS:528: DyaK3sXktVKlu7c%3D
14. MK James A Ray D Leznova SW Blain 2008 Differential modification of p27Kip1 controls its cyclin D-cdk4 inhibitory activity Mol Cell Biol 28 498 510 17908796 10.1128/MCB.02171-06 1:CAS:528:DC%2BD1cXktVaqsw%3D%3D
15. RR Tice E Agurell D Anderson, et al. 2000 Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing Environ Mol Mutagen 35 206 221 10737956 10.1002/(SICI)1098-2280(2000)35:3<206::AID- EM8>3.0.CO;2-J 1:CAS:528:DC%2BD3cXis1Wrurg%3D (Pubitemid 30196665)
16. W Ye L Zhang 2004 Heme deficiency causes apoptosis but does not increase ROS generation in HeLa cells Biochem Biophys Res Commun 319 1065 1071 15194476 10.1016/j.bbrc.2004.05.089 1:CAS:528:DC%2BD2cXkvVCltLk%3D (Pubitemid 38765161)
17. G Martinez C Di Giacomo ML Carnazza, et al. 1997 MAP2, synaptophysin immunostaining in rat brain and behavioral modifications after cerebral postischemic reperfusion Dev Neurosci 19 457 464 9445083 10.1159/000111243 1:CAS:528:DyaK1cXovFWr (Pubitemid 27522436)
18. JN Sarkaria EC Busby RS Tibbetts, et al. 1999 Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine Cancer Res 59 4375 4382 10485486 1:CAS:528:DyaK1MXlvVSmsLs%3D (Pubitemid 29418757)
19. B Zhao MJ Bower PJ McDevitt, et al. 2002 Structural basis for Chk1 inhibition by UCN-01 J Biol Chem 277 46609 46615 12244092 10.1074/jbc.M201233200 1:CAS:528:DC%2BD38XovFKgs7g%3D (Pubitemid 35417660)
20. A Celeste O Fernandez-Capetillo MJ Kruhlak, et al. 2003 Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks Nat Cell Biol 5 675 679 12792649 10.1038/ncb1004 1:CAS:528:DC%2BD3sXkvFeru7k%3D (Pubitemid 36818091)
21. RV Sionov Y Haupt 1999 The cellular response to p53: the decision between life and death Oncogene 18 6145 6157 10557106 10.1038/sj.onc.1203130 1:CAS:528:DyaK1MXns1Oqs7w%3D
22. PJ Murphy MD Galigniana Y Morishima, et al. 2004 Pifithrin-alpha inhibits p53 signaling after interaction of the tumor suppressor protein with hsp90 and its nuclear translocation J Biol Chem 279 30195 30201 15145929 10.1074/jbc.M403539200 1:CAS:528:DC%2BD2cXlsFKitLk%3D (Pubitemid 38937944)
23. RV Kondratov PG Komarov Y Becker A Ewenson AV Gudkov 2001 Small molecules that dramatically alter multidrug resistance phenotype by modulating the substrate specificity of P-glycoprotein Proc Natl Acad Sci USA 98 14078 14083 11707575 10.1073/pnas.241314798 1:CAS:528:DC%2BD3MXovVymsrs%3D (Pubitemid 33116027)
24. E Strom S Sathe PG Komarov, et al. 2006 Small-molecule inhibitor of p53 binding to mitochondria protects mice from gamma radiation Nat Chem Biol 2 474 479 16862141 10.1038/nchembio809 1:CAS:528:DC%2BD28Xot1Gns7w%3D (Pubitemid 44266309)
25. EJ Morris HM Geller 1996 Induction of neuronal apoptosis by camptothecin, an inhibitor of DNA topoisomerase-I: evidence for cell cycle-independent toxicity J Cell Biol 134 757 770 8707853 10.1083/jcb.134.3.757 1:CAS:528:DyaK28XkvVCiu7c%3D (Pubitemid 26269145)
26. DS Park EJ Morris LA Greene HM Geller 1997 G1/S cell cycle blockers and inhibitors of cyclin-dependent kinases suppress camptothecin-induced neuronal apoptosis J Neurosci 17 1256 1270 9006970 1:CAS:528:DyaK2sXhtVGlurg%3D (Pubitemid 27073728)
27. S Seshadri A Beiser J Selhub, et al. 2002 Plasma homocysteine as a risk factor for dementia and Alzheimer's disease N Engl J Med 346 476 483 11844848 10.1056/NEJMoa011613 1:CAS:528:DC%2BD38XhtFCktrw%3D (Pubitemid 34441738)
28. EH Mizrahi A Bowirrat DW Jacobsen, et al. 2004 Plasma homocysteine, vitamin B12 and folate in Alzheimer's patients and healthy Arabs in Israel J Neurol Sci 227 109 113 15546600 10.1016/j.jns.2004.08.011 1:CAS:528: DC%2BD2cXpsl2hsbY%3D (Pubitemid 39491133)
29. LF Agnati S Genedani G Rasio, et al. 2005 Studies on homocysteine plasma levels in Alzheimer's patients. Relevance for neurodegeneration J Neural Transm 112 163 169 15599614 10.1007/s00702-004-0154-7 1:STN:280:DC%2BD2cnisVSmsA%3D%3D (Pubitemid 40104726)
30. Y Ruzankina C Pinzon-Guzman A Asare T Ong L Pontano G Cotsarelis VP Zediak M Velez A Bhandoola EJ Brown 2007 Deletion of the developmentally essential gene ATR in adult mice leads to age-related phenotypes and stem cell loss Cell Stem Cell 1 113 126 18371340 10.1016/j.stem.2007.03.002 1:CAS:528:DC%2BD2sXptV2rs7o%3D (Pubitemid 46865802)
31. S Pauklin A Kristjuhan T Maimets V Jaks 2005 ARF and ATM/ATR cooperate in p53-mediated apoptosis upon oncogenic stress Biochem Biophys Res Commun 334 386 394 16004968 10.1016/j.bbrc.2005.06.097 1:CAS:528:DC%2BD2MXmsVOgsbc%3D (Pubitemid 40982380)
32. Q Liu S Guntuku XS Cui, et al. 2000 Chk1 is an essential kinase that is regulated by ATR and required for the G(2)/M DNA damage checkpoint Genes Dev 14 1448 1459 10859164 10.1101/gad.840500 1:CAS:528:DC%2BD3cXksVGnt78%3D (Pubitemid 30421838)
33. H Takai K Naka Y Okada, et al. 2002 Chk2-deficient mice exhibit radioresistance and defective p53-mediated transcription EMBO J 21 5195 5205 12356735 10.1093/emboj/cdf506 1:CAS:528:DC%2BD38Xns1Cms7Y%3D
34. EC Friedberg 2005 Suffering in silence: the tolerance of DNA damage Nat Rev Mol Cell Biol 6 943 953 16341080 10.1038/nrm1781 1:CAS:528: DC%2BD2MXht1ykurnO (Pubitemid 41778713)
35. Y Zhang D Qu EJ Morris, et al. 2006 The Chk1/Cdc25A pathway as activators of the cell cycle in neuronal death induced by camptothecin J Neurosci 26 8819 8828 16928871 10.1523/JNEUROSCI.2593-06.2006 1:CAS:528:DC%2BD28Xpt1Srs7w%3D (Pubitemid 44319417)
36. L Wohlbold RP Fisher 2009 Behind the wheel and under the hood: functions of cyclin-dependent kinases in response to DNA damage DNA Repair (Amst) 8 1018 1024 10.1016/j.dnarep.2009.04.009 1:CAS:528:DC%2BD1MXps1Wku70%3D
37. A Satyanarayana C Berthet J Lopez-Molina V Coppola L Tessarollo P Kaldis 2008 Genetic substitution of Cdk1 by Cdk2 leads to embryonic lethality and loss of meiotic function of Cdk2 Development 135 3389 3400 18787066 10.1242/dev.024919 1:CAS:528:DC%2BD1cXhsVarur%2FF
38. C Vogel C Hager H Bastians 2007 Mechanisms of mitotic cell death induced by chemotherapy-mediated G2 checkpoint abrogation Cancer Res 67 339 345 17210716 10.1158/0008-5472.CAN-06-2548 1:CAS:528:DC%2BD2sXisFSrtA%3D%3D (Pubitemid 46142793)
39. AN Tse GK Schwartz 2004 Potentiation of cytotoxicity of topoisomerase I poison by concurrent and sequential treatment with the checkpoint inhibitor UCN-01 involves disparate mechanisms resulting in either p53-independent clonogenic suppression or p53-dependent mitotic catastrophe Cancer Res 64 6635 6644 15374978 10.1158/0008-5472.CAN-04-0841 1:CAS:528:DC%2BD2cXnsFOlu7o%3D (Pubitemid 39297924)
40. K Myers ME Gagou P Zuazua-Villar R Rodriguez M Meuth 2009 ATR and Chk1 suppress a caspase-3-dependent apoptotic response following DNA replication stress PLoS Genet 5 e1000324 19119425 10.1371/journal.pgen.1000324
41. TA Evans AK Raina A Delacourte, et al. 2007 BRCA1 may modulate neuronal cell cycle re-entry in Alzheimer disease Int J Med Sci 4 140 145 17505559 1:CAS:528:DC%2BD2sXptlKku7k%3D (Pubitemid 46743287)
42. A Thakur SL Siedlak SL James, et al. 2008 Retinoblastoma protein phosphorylation at multiple sites is associated with neurofibrillary pathology in Alzheimer disease Int J Clin Exp Pathol 1 134 146 18784806 1:CAS:528:DC%2BD1cXpt1GmsrY%3D
43. C Lanni M Racchi S Stanga, et al. 2010 Unfolded p53 in blood as a predictive signature signature of the transition from mild cognitive impairment to Alzheimer's disease J Alzheimers Dis 20 97 104 20164600 1:CAS:528: DC%2BC3cXksV2msrc%3D
44. C Wilson S Henry MA Smith R Bowser 2004 The p53 homologue p73 accumulates in the nucleus and localizes to neurites and neurofibrillary tangles in Alzheimer disease brain Neuropathol Appl Neurobiol 30 19 29 14720173 10.1046/j.0305-1846.2003.00496.x 1:CAS:528:DC%2BD2cXitVGjurg%3D (Pubitemid 38177999)
45. X Zhu AK Raina H Boux ZL Simmons A Takeda MA Smith 2000 Activation of oncogenic pathways in degenerating neurons in Alzheimer disease Int J Dev Neurosci 18 433 437 10817927 10.1016/S0736-5748(00)00010-1 1:CAS:528: DC%2BD3cXks1Sqs7w%3D (Pubitemid 30243073)
46. A McShea AF Wahl MA Smith 1999 Re-entry into the cell cycle: a mechanism for neurodegeneration in Alzheimer disease Med Hypotheses 52 525 527 10459833 10.1054/mehy.1997.0680 1:CAS:528:DyaK1MXltlOiur0%3D (Pubitemid 29322571)
47. KL Jordan-Sciutto LM Malaiyandi R Bowser 2002 Altered distribution of cell cycle transcriptional regulators during Alzheimer disease J Neuropathol Exp Neurol 61 358 367 11939591 1:CAS:528:DC%2BD38XjtFSlur0%3D (Pubitemid 34266787)